Literature DB >> 30661029

Suicide in Parkinson's disease.

Melissa Deanna Shepard1, Kate Perepezko2, Martijn P G Broen3, Jared Thomas Hinkle2,4, Ankur Butala2,5, Kelly A Mills5,6, Julie Nanavati2, Nicole Mercado Fischer2, Paul Nestadt2, Gregory Pontone2,6.   

Abstract

Persons with Parkinson's disease (PwP) have many known risk factors for suicide and suicidal ideation (SI). Despite this, there is limited understanding of suicidality in this population. We conducted a systematic review to synthesise the available literature on suicidality in PwP and highlight areas for potential intervention and further research. We identified 116 articles discussing SI, suicidal behaviours, suicide attempts and/or fatal suicide in PwP. These articles describe prevalence, suicide methods, risk factors for suicide and SI and treatment of suicidality. In this review, we summarise the current literature and provide suggestions for how clinicians can identify and treat PwP who are at risk for suicide, for example, through aggressive treatment of depression and improved screening for access to lethal means. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Parkinson's disease; movement disorders; neuropsychiatry; psychiatry

Mesh:

Year:  2019        PMID: 30661029      PMCID: PMC7187903          DOI: 10.1136/jnnp-2018-319815

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  119 in total

1.  Suicide after successful deep brain stimulation for movement disorders.

Authors:  A Albanese; S Piacentini; L M A Romito; M Leone; A Franzini; G Broggi; G Bussone
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

Review 2.  Suicide and suicidal behavior.

Authors:  Matthew K Nock; Guilherme Borges; Evelyn J Bromet; Christine B Cha; Ronald C Kessler; Sing Lee
Journal:  Epidemiol Rev       Date:  2008-07-24       Impact factor: 6.222

3.  Suicidal risk factors and completed suicide: meta-analyses based on psychological autopsy studies.

Authors:  Kouichi Yoshimasu; Chikako Kiyohara; Kazuhisa Miyashita
Journal:  Environ Health Prev Med       Date:  2008-06-19       Impact factor: 3.674

Review 4.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

5.  Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis.

Authors:  Sergio Starkstein; Milan Dragovic; Ricardo Jorge; Simone Brockman; Marcelo Merello; Robert G Robinson; David Bruce; Mark Wilson
Journal:  Mov Disord       Date:  2011-07-07       Impact factor: 10.338

6.  Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients pre- and post-deep brain stimulation.

Authors:  Er-Song Wang; Hui-Bin Yao; Ying-Hui Chen; Gan Wang; Wen-Wei Gao; Yi-Rui Sun; Ji-Guang Guo; Jian-Wen Hu; Cheng-Chuan Jiang; Jin Hu
Journal:  Cell Physiol Biochem       Date:  2013-05-06

7.  Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.

Authors:  Sun Ju Chung; Mahnaz Asgharnejad; Lars Bauer; Francisco Ramirez; Beomseok Jeon
Journal:  Expert Opin Pharmacother       Date:  2016-07-07       Impact factor: 3.889

8.  Neuroversion: using electroconvulsive therapy as a bridge to deep brain stimulation implantation.

Authors:  Nolan R Williams; Greg Sahlem; Jaspreet Pannu; Istvan Takacs; Baron Short; Gonzalo Revuelta; Mark S George
Journal:  Neurocase       Date:  2017-02-07       Impact factor: 0.881

9.  Surviving 10 years with deep brain stimulation for Parkinson's disease--a follow-up of 79 patients.

Authors:  M Bang Henriksen; E L Johnsen; N Sunde; A Vase; M C Gjelstrup; K Østergaard
Journal:  Eur J Neurol       Date:  2014-12-09       Impact factor: 6.089

10.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

View more
  7 in total

1.  A dyadic study of psychological well-being of individuals with Parkinson's disease and their caregivers.

Authors:  Yu Lee; Yu-Jie Chiou; Chi-Fa Hung; Yung-Yee Chang; Ying-Fa Chen; Tsu-Kung Lin; Liang-Jen Wang
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

2.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

3.  Parkinson's Disease-Related Risk of Suicide and Effect of Deep Brain Stimulation: Meta-Analysis.

Authors:  Juncong Du; Xi Liu; Xuan Zhou; Hui Wang; Wen Zhou; Jin Jiang; Wuxue Peng; Lijuan Mo; Changhong Tan; Lifen Chen
Journal:  Parkinsons Dis       Date:  2020-09-27

4.  Association between new-onset Parkinson's disease and suicide risk in South Korea: a nationwide cohort study.

Authors:  Sung Hoon Jeong; Seung Hoon Kim; Doo Woong Lee; Eun-Cheol Park; Suk-Yong Jang
Journal:  BMC Psychiatry       Date:  2022-05-17       Impact factor: 4.144

Review 5.  The neuropsychiatry of Parkinson's disease: advances and challenges.

Authors:  Daniel Weintraub; Dag Aarsland; Kallol Ray Chaudhuri; Roseanne D Dobkin; Albert Fg Leentjens; Mayela Rodriguez-Violante; Anette Schrag
Journal:  Lancet Neurol       Date:  2022-01       Impact factor: 44.182

6.  Assisted Suicide in Parkinsonian Disorders.

Authors:  Georg S Nuebling; Elisabeth Butzhammer; Stefan Lorenzl
Journal:  Front Neurol       Date:  2021-03-15       Impact factor: 4.003

7.  A Systematic Review of Neuromodulation Treatment Effects on Suicidality.

Authors:  Mehmet Utku Kucuker; Ammar G Almorsy; Ayse Irem Sonmez; Anna N Ligezka; Deniz Doruk Camsari; Charles P Lewis; Paul E Croarkin
Journal:  Front Hum Neurosci       Date:  2021-06-25       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.